UroGen Pharma

+$0.05 (+0.29%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell UroGen Pharma and other stocks, options, and ETFs commission-free!

About URGN

UroGen Pharma Ltd. Ordinary Shares, also called UroGen Pharma, is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases.

CEO
Elizabeth Barrett
Employees
187
Headquarters
Princeton, New Jersey
Founded
2004

URGN Key Statistics

Market Cap
413.45M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
132.99K
High Today
$17.54
Low Today
$17.06
Open Price
$17.46
Volume
78.60K
52 Week High
$30.89
52 Week Low
$14.66

URGN Earnings

-$1.86
-$1.24
-$0.62
-$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure